Computational Models for Identifying Promiscuous HLA-B7 Binders based on Information Theory and Support Vector Machine
暂无分享,去创建一个
Joo Chuan Tong | Chee Keong Kwoh | Yun Zheng | Guang Lan Zhang | Zong Hong Zhang | V. Brusic | J.T. August | J. Tong | V. Brusic | C. Kwoh | Z. H. Zhang | G. Zhang | Yun Zheng | J. August
[1] Kiyoshi Miwa,et al. Residue 116 determines the C-terminal anchor residue of HLA-B*3501 and -B*5101 binding peptides but does not explain the general affinity difference , 1998, Immunogenetics.
[2] A Sette,et al. The development of multi-epitope vaccines: epitope identification, vaccine design and clinical evaluation. , 2001, Biologicals : journal of the International Association of Biological Standardization.
[3] J. Sidney,et al. HLA supertypes and supermotifs: a functional perspective on HLA polymorphism. , 1998, Current opinion in immunology.
[4] Chee Keong Kwoh,et al. Dynamic algorithm for inferring qualitative models of Gene Regulatory Networks , 2006, Int. J. Data Min. Bioinform..
[5] M F del Guercio,et al. Definition of an HLA-A3-like supermotif demonstrates the overlapping peptide-binding repertoires of common HLA molecules. , 1996, Human immunology.
[6] T. Williams. Human leukocyte antigen gene polymorphism and the histocompatibility laboratory. , 2001, The Journal of molecular diagnostics : JMD.
[7] Vladimir Brusic,et al. Computational binding assays of antigenic peptides , 2006, Letters in Peptide Science.
[8] Vladimir N. Vapnik,et al. The Nature of Statistical Learning Theory , 2000, Statistics for Engineering and Information Science.
[9] J Alexander,et al. Optimizing vaccine design for cellular processing, MHC binding and TCR recognition. , 2002, Tissue antigens.
[10] A Sette,et al. Practical, biochemical and evolutionary implications of the discovery of HLA class I supermotifs. , 1996, Immunology today.
[11] Vladimir Brusic,et al. Predictive Vaccinology: Optimisation of Predictions Using Support Vector Machine Classifiers , 2005, IDEAL.
[12] Arne Elofsson,et al. Prediction of MHC class I binding peptides, using SVMHC , 2002, BMC Bioinformatics.
[13] Hong Zhang,et al. EPIMHC: a curated database of MHC-binding peptides for customized computational vaccinology , 2005, Bioinform..
[14] J. Sidney,et al. Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism , 1999, Immunogenetics.
[15] Takamasa Ueno,et al. Single T Cell Receptor-Mediated Recognition of an Identical HIV-Derived Peptide Presented by Multiple HLA Class I Molecules1 , 2002, The Journal of Immunology.
[16] Irini A. Doytchinova,et al. JenPep: a database of quantitative functional peptide data for immunology , 2002, Bioinform..
[17] Bing Zhao,et al. A novel MHCp binding prediction model. , 2003, Human immunology.
[18] Vladimir Brusic,et al. Prediction of promiscuous peptides that bind HLA class I molecules , 2002, Immunology and cell biology.
[19] H. Rammensee,et al. SYFPEITHI: database for MHC ligands and peptide motifs , 1999, Immunogenetics.
[20] Yun. Zheng. Information learning approach , 2007 .
[21] L. Tussey,et al. Mapping and binding analysis of peptides derived from the tumor-associated antigen survivin for eight HLA alleles. , 2005, Cancer immunity.
[22] G. Chelvanayagam. A roadmap for HLA-A, HLA-B, and HLA-C peptide binding specificities , 1996, Immunogenetics.
[23] Vladimir Brusic,et al. Neural Models for Predicting Viral Vaccine Targets , 2005, J. Bioinform. Comput. Biol..
[24] S Brunak,et al. Sensitive quantitative predictions of peptide-MHC binding by a 'Query by Committee' artificial neural network approach. , 2003, Tissue antigens.
[25] Vladimir Brusic,et al. MULTIPRED: a computational system for prediction of promiscuous HLA binding peptides , 2005, Nucleic Acids Res..
[26] Kwoh Chee Keong,et al. Dynamic algorithm for inferring qualitative models of gene regulatory networks , 2004 .
[27] J A Swets,et al. Measuring the accuracy of diagnostic systems. , 1988, Science.
[28] C. Schönbach,et al. Fine tuning of peptide binding to HLA-B*3501 molecules by nonanchor residues. , 1995, Journal of immunology.
[29] S. Brunak,et al. SARS CTL vaccine candidates; HLA supertype‐, genome‐wide scanning and biochemical validation , 2004, Tissue antigens.
[30] Francine Jotereau,et al. Identification of Five New HLA-B*3501-Restricted Epitopes Derived from Common Melanoma-Associated Antigens, Spontaneously Recognized by Tumor-Infiltrating Lymphocytes 1 , 2003, The Journal of Immunology.
[31] Lucy Dorrell,et al. Cytotoxic T lymphocytes recognize structurally diverse, clade‐specific and cross‐reactive peptides in human immunodeficiency virus type‐1 gag through HLA‐B53 , 2001, European journal of immunology.
[32] Alessandro Sette,et al. Development of a DNA Vaccine Designed to Induce Cytotoxic T Lymphocyte Responses to Multiple Conserved Epitopes in HIV-1 1 , 2003, The Journal of Immunology.
[33] M F del Guercio,et al. Specificity and degeneracy in peptide binding to HLA-B7-like class I molecules. , 1996, Journal of immunology.
[34] L C Harrison,et al. MHCPEP: a database of MHC-binding peptides. , 1994, Nucleic acids research.
[35] M F del Guercio,et al. Several HLA alleles share overlapping peptide specificities. , 1995, Journal of immunology.
[36] S. Oka,et al. Identification of multiple HIV-1 CTL epitopes presented by HLA-B*5101 molecules. , 1999, Human immunology.
[37] Zheng Yun,et al. Identifying simple discriminatory gene vectors with an information theory approach , 2005, 2005 IEEE Computational Systems Bioinformatics Conference (CSB'05).